Projected Income Statement: Exact Sciences Corporation

Forecast Balance Sheet: Exact Sciences Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 -497 1,150 1,604 1,537 1,283 1,457 1,185 786
Change - 331.39% 39.48% -4.18% -16.53% 13.56% -18.67% -33.67%
Announcement Date 2/16/21 2/22/22 2/21/23 2/21/24 2/19/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: Exact Sciences Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 64.35 135.8 214.5 124.2 136 138.4 160.6 165.8
Change - 110.97% 57.96% -42.09% 9.5% 1.79% 16.01% 3.24%
Free Cash Flow (FCF) 1 72.13 -238 -438 31.93 74.55 274.2 447.8 621.8
Change - -429.96% -84.04% 107.29% 133.48% 267.77% 63.34% 38.84%
Announcement Date 2/16/21 2/22/22 2/21/23 2/21/24 2/19/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Exact Sciences Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 1.75% -10.64% -6.88% 8.75% 11.72% 14.17% 17.18% 20.12%
EBIT Margin (%) -9.21% -33.92% -27.83% -10.36% -5.31% -3.13% 1.43% 4.7%
EBT Margin (%) -57.47% -47.68% -30.35% -8.07% -37.56% -3.98% 1.25% 5.21%
Net margin (%) -56.9% -33.71% -29.91% -8.17% -37.29% -3.98% 1.34% 5.24%
FCF margin (%) 4.84% -13.47% -21.02% 1.28% 2.7% 8.86% 12.84% 15.88%
FCF / Net Income (%) -8.5% 39.96% 70.25% -15.64% -7.25% -222.7% 958.9% 302.98%

Profitability

        
ROA -20.13% -10.26% -9.16% -4.42% -0.68% 1% 3% 5%
ROE -33.2% -21.18% -18.38% -9.08% -1.52% -2.25% 4.97% 9.71%

Financial Health

        
Leverage (Debt/EBITDA) - -6.11x -11.19x 7.02x 3.97x 3.32x 1.98x 1x
Debt / Free cash flow - -4.83x -3.66x 48.13x 17.21x 5.31x 2.65x 1.26x

Capital Intensity

        
CAPEX / Current Assets (%) 4.31% 7.68% 10.29% 4.97% 4.93% 4.47% 4.6% 4.23%
CAPEX / EBITDA (%) 246.78% -72.19% -149.57% 56.77% 42.05% 31.58% 26.8% 21.04%
CAPEX / FCF (%) 89.22% -57.04% -48.96% 388.96% 182.42% 50.49% 35.86% 26.66%

Items per share

        
Cash flow per share 1 0.82 -0.5967 -1.268 0.8666 1.143 0.8336 1.707 -
Change - -172.76% -112.46% 168.36% 31.89% -27.07% 104.76% -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 18.68 19.77 17.26 17.34 12.94 14.11 16.18 19.06
Change - 5.83% -12.72% 0.5% -25.37% 9.02% 14.66% 17.83%
EPS 1 -5.61 -3.48 -3.54 -1.13 -5.59 -0.5634 0.2886 1.097
Change - 37.97% -1.72% 68.08% -394.69% 89.92% 151.22% 280.21%
Nbr of stocks (in thousands) 159,030 172,319 177,684 180,850 185,076 188,638 188,638 188,638
Announcement Date 2/16/21 2/22/22 2/21/23 2/21/24 2/19/25 - - -
1USD
Estimates
2025 *2026 *
P/E ratio -95x 185x
PBR 3.79x 3.31x
EV / Sales 3.73x 3.23x
Yield - -
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
53.52USD
Average target price
68.86USD
Spread / Average Target
+28.66%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EXAS Stock
  4. Financials Exact Sciences Corporation